La vendita allo scoperto per Bird Global Inc Class A dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Bird Global Inc Class A. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Bird Global Inc Class A (OTC:BRDSQ) Azioni, Report sulle vendite allo scoperto

Bird Global Inc Class A

<p>RBC Capital  analyst Ben Hendrix   maintains Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Sector Perform and lowers the price target from $211 to $201.</p>


News

Price Target

Analyst Ratings

RBC Capital Maintains Sector Perform on Universal Health Services, Lowers Price Target to $201

<p>RBC Capital  analyst Nik Modi   maintains Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) with a Outperform and raises the price target from $73 to $76.</p>


RBC Capital Maintains Outperform on Coca-Cola, Raises Price Target to $76

<p>Travere Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) will release its quarterly earnings report on Thursday, 2025-05-01. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Travere Therapeutics to report an <strong>earnings per share</strong> (EPS) of $-0.36.</p>
<p>The market awaits Travere Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $0.09, which was followed by a 6.79% drop in the share price the next day.</p>
<p>Here's a look at Travere Therapeutics's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.38</td>
<td>-0.68</td>
<td>-0.86</td>
<td>-0.99</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.47</td>
<td>-0.46</td>
<td>-0.65</td>
<td>-1.51</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>0.0%</td>
<td>-3.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039781_0.png" alt="eps graph" /></p>
<h3>Travere Therapeutics Share Price Analysis</h3>
<p>Shares of Travere Therapeutics were trading at $20.08 as of April 29. Over the last 52-week period, shares are up 236.04%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/TVTX/earnings"><strong>To track all earnings releases for Travere Therapeutics visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

TVTX

Travere Therapeutics's Earnings: A Preview

<p>LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) will release its quarterly earnings report on Thursday, 2025-05-01. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate LendingTree to report an <strong>earnings per share</strong> (EPS) of $0.65.</p>
<p>The market awaits LendingTree's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS beat by $0.63 in the last quarter, leading to a 22.52% increase in the share price on the following day.</p>
<p>Here's a look at LendingTree's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.53</td>
<td>0.66</td>
<td>0.46</td>
<td>0.36</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.16</td>
<td>0.80</td>
<td>0.54</td>
<td>0.70</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>23.0%</td>
<td>-21.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039773_0.png" alt="eps graph" /></p>
<h3>Tracking LendingTree's Stock Performance</h3>
<p>Shares of LendingTree were trading at $53.02 as of April 29. Over the last 52-week period, shares are up 4.22%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Insights Shared by Analysts on LendingTree</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on LendingTree.</p>
<p>With 4 analyst ratings, LendingTree has a consensus rating of Outperform. The average one-year price target is $67.0, indicating a potential 26.37% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of  and Nerdwallet, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Nerdwallet, with an average 1-year price target of $14.0, suggesting a potential 73.59% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>In the peer analysis summary, key metrics for  and Nerdwallet are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>LendingTree</td>
<td>Outperform</td>
<td>94.65%</td>
<td>$251.78M</td>
<td>7.39%</td>
</tr>
<tr>
<td>Nerdwallet</td>
<td>Neutral</td>
<td>37.47%</td>
<td>$167.10M</td>
<td>11.24%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>LendingTree ranks higher in Revenue Growth compared to its peers. It also has a lower Gross Profit margin. However, its Return on Equity is lower than the peer average. Overall, LendingTree is positioned in the middle among its peers based on the provided metrics.</p>
<h3>All You Need to Know About LendingTree</h3>
<p>LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.</p>
<h3>Key Indicators: LendingTree's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> LendingTree displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>94.65%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> LendingTree's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>2.87%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> LendingTree's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>7.39%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> LendingTree's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.97%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>5.0</strong>, LendingTree faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/TREE/earnings"><strong>To track all earnings releases for LendingTree visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


TREE

Preview: LendingTree's Earnings

<p>Materion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTRN#NYSE">MTRN</a>) is preparing to release its quarterly earnings on Thursday, 2025-05-01. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Materion to report an <strong>earnings per share</strong> (EPS) of $1.04.</p>
<p>Materion bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings Track Record</h3>
<p>In the previous earnings release, the company missed EPS by $0.01, leading to a 3.39% drop in the share price the following trading session.</p>
<p>Here's a look at Materion's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.45</td>
<td>1.41</td>
<td>1.41</td>
<td>0.96</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.44</td>
<td>1.41</td>
<td>1.42</td>
<td>0.96</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>-3.0%</td>
<td>11.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039763_0.png" alt="eps graph" /></p>
<h3>Market Performance of Materion's Stock</h3>
<p>Shares of Materion were trading at $83.16 as of April 29. Over the last 52-week period, shares are down 24.96%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MTRN/earnings"><strong>To track all earnings releases for Materion visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MTRN

Earnings Preview: Materion

<p>MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-01. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that MGP Ingredients will report an <strong>earnings per share</strong> (EPS) of $0.37.</p>
<p>Investors in MGP Ingredients are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the last quarter, the company reported an EPS beat by $0.07, leading to a 3.23% increase in the share price on the subsequent day.</p>
<p>Here's a look at MGP Ingredients's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.50</td>
<td>1.25</td>
<td>1.56</td>
<td>0.98</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.57</td>
<td>1.29</td>
<td>1.71</td>
<td>1.07</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-5.0%</td>
<td>-1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039756_0.png" alt="eps graph" /></p>
<h3>Performance of MGP Ingredients Shares</h3>
<p>Shares of MGP Ingredients were trading at $29.55 as of April 29. Over the last 52-week period, shares are down 64.16%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analyst Opinions on MGP Ingredients</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding MGP Ingredients.</p>
<p>Analysts have given MGP Ingredients a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $39.0, indicating a potential 31.98% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of  and MGP Ingredients, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for  and MGP Ingredients, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>MGP Ingredients</td>
<td>Buy</td>
<td>-15.87%</td>
<td>$74.47M</td>
<td>-4.75%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>MGP Ingredients ranks at the bottom for Revenue Growth among its peers. It also ranks at the bottom for Gross Profit. Additionally, it is at the bottom for Return on Equity. Overall, MGP Ingredients is positioned at the bottom compared to its peers across all key metrics.</p>
<h3>Unveiling the Story Behind MGP Ingredients</h3>
<p>MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.</p>
<h3>Key Indicators: MGP Ingredients's Financial Health</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> MGP Ingredients's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately <strong>-15.87%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-22.96%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> MGP Ingredients's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-4.75%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> MGP Ingredients's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>-2.92%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> MGP Ingredients's debt-to-equity ratio is below the industry average. With a ratio of <b>0.41</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/MGPI/earnings"><strong>To track all earnings releases for MGP Ingredients visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MGPI

Preview: MGP Ingredients's Earnings

<p>Mercer Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MERC#NASDAQ">MERC</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-01. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Mercer Intl will report an <strong>earnings per share</strong> (EPS) of $-0.19.</p>
<p>The market awaits Mercer Intl's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.20, leading to a 16.87% increase in the share price the following trading session.</p>
<p>Here's a look at Mercer Intl's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.05</td>
<td>0.08</td>
<td>-0.31</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.25</td>
<td>-0.26</td>
<td>-1.01</td>
<td>-0.25</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>17.0%</td>
<td>-0.0%</td>
<td>0.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039748_0.png" alt="eps graph" /></p>
<h3>Mercer Intl Share Price Analysis</h3>
<p>Shares of Mercer Intl were trading at $4.61 as of April 29. Over the last 52-week period, shares are down 86.96%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analysts' Perspectives on Mercer Intl</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Mercer Intl.</p>
<p>The consensus rating for Mercer Intl is Neutral, based on 1 analyst ratings. With an average one-year price target of $6.0, there's a potential 30.15% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Clearwater Paper, Magnera and Sylvamo, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Clearwater Paper, with an average 1-year price target of $37.0, suggesting a potential 702.6% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Magnera, with an average 1-year price target of $24.0, suggesting a potential 420.61% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Sylvamo, with an average 1-year price target of $80.0, suggesting a potential 1635.36% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>In the peer analysis summary, key metrics for Clearwater Paper, Magnera and Sylvamo are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mercer Intl</td>
<td>Neutral</td>
<td>3.81%</td>
<td>$76.18M</td>
<td>3.53%</td>
</tr>
<tr>
<td>Clearwater Paper</td>
<td>Outperform</td>
<td>44.12%</td>
<td>$14.70M</td>
<td>26.21%</td>
</tr>
<tr>
<td>Magnera</td>
<td>Outperform</td>
<td>119.11%</td>
<td>$71M</td>
<td>-9.14%</td>
</tr>
<tr>
<td>Sylvamo</td>
<td>Neutral</td>
<td>0.62%</td>
<td>$237M</td>
<td>9.08%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Mercer Intl ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.</p>
<h3>Delving into Mercer Intl's Background</h3>
<p>Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.</p>
<h3>A Deep Dive into Mercer Intl's Financials</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Mercer Intl showcased positive performance, achieving a revenue growth rate of <strong>3.81%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Mercer Intl's net margin excels beyond industry benchmarks, reaching <strong>3.42%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Mercer Intl's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>3.53%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Mercer Intl's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.7%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>3.47</strong>, Mercer Intl faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/MERC/earnings"><strong>To track all earnings releases for Mercer Intl visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MERC

Insights Ahead: Mercer Intl's Quarterly Earnings

<p>RBC Capital  analyst Ben Hendrix   maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Outperform and raises the price target from $183 to $189.</p>


RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $189

<p>Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-01. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Kura Oncology will report an <strong>earnings per share</strong> (EPS) of $-0.60.</p>
<p>Anticipation surrounds Kura Oncology's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>During the last quarter, the company reported an EPS beat by $0.42, leading to a 1.54% drop in the share price on the subsequent day.</p>
<p>Here's a look at Kura Oncology's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.64</td>
<td>-0.63</td>
<td>-0.63</td>
<td>-0.55</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.22</td>
<td>-0.63</td>
<td>-0.59</td>
<td>-0.59</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039736_0.png" alt="eps graph" /></p>
<h3>Market Performance of Kura Oncology's Stock</h3>
<p>Shares of Kura Oncology were trading at $6.52 as of April 29. Over the last 52-week period, shares are down 68.21%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/KURA/earnings"><strong>To track all earnings releases for Kura Oncology visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


KURA

Uncovering Potential: Kura Oncology's Earnings Preview

<p>Mobile learning platform <strong>Duolingo Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) has <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g45093631/duolingo-launches-148-new-language-courses-expands-access-to-popular-languages-including-japanese-" rel="noreferrer noopener">introduced its most extensive </a>course expansion to date, launching 148 new language programs on its platform.</p>
<p>This substantial growth more than doubles its existing offerings. The launch makes Duolingo's top seven non-English languages, Spanish, French, German, Italian, Japanese, Korean, and Mandarin accessible across all 28 of its supported interface languages.</p>
<p>In the past, developing a single language course on Duolingo could take several years. But with the help of generative AI, enhanced internal tools, and a new shared content system, the company has shortened that process, rolling out its newest set of courses in less than a year.</p>
<p><strong>Also Read: <em><a target="_blank" href="https://www.benzinga.com/news/25/04/45040811/marriott-bets-355m-on-trendy-citizenm-hotels-to-woo-modern-travelers" rel="noreferrer noopener">Marriott Bets $355M On Trendy CitizenM Hotels To Woo Modern Travelers</a></em></strong></p>
<p>"Developing our first 100 courses took about 12 years, and now, in about a year, we're able to create and launch nearly 150 new courses. This is a great example of how generative AI can directly benefit our learners," said CEO and co-founder <strong>Luis von Ahn</strong>.</p>
<p>This shared content model enables the creation of a core course structure that can be quickly adapted for multiple languages.</p>
<p>The majority of the newly launched courses are designed for beginners, aligning with A1–A2 levels on the CEFR scale, and include interactive tools such as Stories and DuoRadio to help reading and listening comprehension.</p>
<p>Duolingo noted that higher-level content is expected to be added in the coming months.</p>
<p>The release is especially impactful in regions where access to non-English courses was previously limited. In Latin America, Spanish and Portuguese speakers now have access to Asian languages like Japanese, Mandarin, and Korean.</p>
<p>In Europe, learners speaking languages such as French, German, or Italian can also explore these new additions.</p>
<p>Meanwhile, in Asia, speakers of languages like Hindi, Thai, and Tamil can now learn any of the top seven languages, whereas previously, their options were largely restricted to English.</p>
<p><strong>Price Action</strong>: DUOL shares traded higher by 0.35% at $386.48 at last check Wednesday.</p>
<p><strong>Read Next</strong>:</p>
<ul>
<li><strong><em><a href="https://www.benzinga.com/news/25/04/45011895/the-future-of-flight-united-airlines-invests-in-radical-jet-design" target="_blank" rel="noreferrer noopener">The Future of Flight? United Airlines Invests In Radical Jet Design</a></em></strong></li>
</ul>
<p><em>Photo by DANIEL CONSTANTE via Shutterstock</em></p>


Tech

General

DUOL

Duolingo Launches Its Biggest Expansion Yet With 148 New Courses

<p><strong>Xerox Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Xerox Holdings will report an <strong>earnings per share</strong> (EPS) of $0.21. </p>
<p>Anticipation surrounds Xerox Holdings's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company missed EPS by $0.13, which was followed by a 5.79% drop in the share price the next day.</p>
<p>Here's a look at Xerox Holdings's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.49</td>
<td>0.51</td>
<td>0.43</td>
<td>0.35</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.36</td>
<td>0.25</td>
<td>0.29</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>-3.0%</td>
<td>2.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039719_0.png" alt="eps graph" /></p>
<h3>Market Performance of Xerox Holdings's Stock</h3>
<p>Shares of Xerox Holdings were trading at $4.44 as of April 29. Over the last 52-week period, shares are down 67.18%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/XRX/earnings"><strong>To track all earnings releases for Xerox Holdings visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from Xerox Holdings's Earnings

<p><strong>Illinois Tool Works Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITW#NYSE">ITW</a>) stock was trading lower on Wednesday after the company reported better-than-expected <a href="https://www.benzinga.com/pressreleases/25/04/g45097281/itw-reports-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">first-quarter 2025 results</a>.</p>
<p>The company reported revenue of $3.84 billion, a 3.4% decline year over year, which aligns with the consensus estimate. EPS for the quarter stood at $2.38, down from $2.73 YoY and above the consensus of $2.36.</p>
<p>Organic revenue declined by 1.6%, while organic revenue remained nearly flat on an equal-day basis. Foreign currency translation had a negative impact of 1.8% on revenue.</p>
<p>Revenue By Segments: Automotive OEM $786 million (-3.7% YoY), Food Equipment $627 million (-0.7% YoY), Test &amp; Measurement and Electronics $652 million (-6.3% YoY), Welding $472 million (-0.9% YoY), Polymers &amp; Fluids $429 million (-0.8% YoY), Construction Products $443 million (-9.2% YoY) and Specialty Products $435 million (-1% YoY).</p>
<p>Operating income decreased 15.6% year over year to $951 million, and the operating margin contracted 360 bps to 24.8%. Enterprise initiatives contributed 120 basis points, offset by higher restructuring expenses from 80/20 projects and one-time items.</p>
<p>ITW&#8217;s operating cash flow was $592 million for the quarter, with free cash flow of $496 million, reflecting a 71% conversion to net income. The company repurchased $375 million of its shares during the quarter.</p>
<p>&#8220;Acknowledging the uncertain external environment, we are maintaining our full year 2025 guidance as we expect our ongoing pricing actions to offset tariff cost impacts. ITW is built to outperform in today&#8217;s volatile environment,&#8221; commented <strong>Christopher A. O&#8217;Herlihy</strong>, president and CEO.</p>
<p>&#8220;Our largely &#8216;produce where we sell&#8217; manufacturing strategy, decentralized operating culture which enables rapid &#8216;read and react&#8217; response, and diversified high-quality business portfolio all provide resilience during times of volatility and uncertainty. Our strong financial profile allows us to maintain our strategic investments and focus on driving continued progress on our long-term strategy to make above-market organic growth, fueled by Customer-back Innovation, into a core ITW strength,&#8221; O&#8217;Herlihy concluded.</p>
<p><strong>2025 Guidance reaffirmed:</strong> ITW maintains its GAAP EPS guidance of $10.15 – $10.55 versus the consensus of $10.27.</p>
<p>Revenue and organic growth are projected to be 0-2%, with an operating margin expected between 26.5% and 27.5%.</p>
<p>The free cash flow is expected to exceed 100% of net income, and the company plans to repurchase $1.5 billion in shares. The projected effective tax rate is 24%.</p>
<p><strong>Price Action:</strong> ITW shares traded lower by 3.58% at $233.10 at the last check Wednesday.</p>
<p><em>Photo: Shutterstock</em></p>


Guidance

Illinois Tool Works Faces Q1 Revenue Dip And Lower EPS, Maintains 2025 Guidance Amid Uncertainty

<p>LeMaitre Vascular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMAT#NASDAQ">LMAT</a>) will release its quarterly earnings report on Thursday, 2025-05-01. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate LeMaitre Vascular to report an <strong>earnings per share</strong> (EPS) of $0.50.</p>
<p>The market awaits LeMaitre Vascular's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.00, which was followed by a 8.07% drop in the share price the next day.</p>
<p>Here's a look at LeMaitre Vascular's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.49</td>
<td>0.43</td>
<td>0.47</td>
<td>0.39</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.49</td>
<td>0.49</td>
<td>0.53</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-8.0%</td>
<td>7.000000000000001%</td>
<td>-1.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039689_0.png" alt="eps graph" /></p>
<h3>Performance of LeMaitre Vascular Shares</h3>
<p>Shares of LeMaitre Vascular were trading at $92.6 as of April 29. Over the last 52-week period, shares are up 34.81%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on LeMaitre Vascular</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on LeMaitre Vascular.</p>
<p>The consensus rating for LeMaitre Vascular is Buy, derived from 3 analyst ratings. An average one-year price target of $105.0 implies a potential 13.39% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of NovoCure, Enovis and QuidelOrtho, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for NovoCure, with an average 1-year price target of $29.67, suggesting a potential 67.96% downside.</li>
<li>Analysts currently favor an Buy trajectory for Enovis, with an average 1-year price target of $64.0, suggesting a potential 30.89% downside.</li>
<li>Analysts currently favor an Neutral trajectory for QuidelOrtho, with an average 1-year price target of $43.67, suggesting a potential 52.84% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>The peer analysis summary outlines pivotal metrics for NovoCure, Enovis and QuidelOrtho, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>LeMaitre Vascular</td>
<td>Buy</td>
<td>13.98%</td>
<td>$38.59M</td>
<td>3.35%</td>
</tr>
<tr>
<td>NovoCure</td>
<td>Neutral</td>
<td>11.91%</td>
<td>$116.47M</td>
<td>-9.50%</td>
</tr>
<tr>
<td>Enovis</td>
<td>Buy</td>
<td>23.29%</td>
<td>$307.52M</td>
<td>-23.87%</td>
</tr>
<tr>
<td>QuidelOrtho</td>
<td>Neutral</td>
<td>-4.69%</td>
<td>$326.10M</td>
<td>-5.78%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>LeMaitre Vascular ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the lowest Return on Equity. Overall, LeMaitre Vascular is positioned favorably compared to its peers in terms of financial performance.</p>
<h3>About LeMaitre Vascular</h3>
<p>LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.</p>
<h3>A Deep Dive into LeMaitre Vascular's Financials</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> LeMaitre Vascular's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>13.98%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> LeMaitre Vascular's net margin is impressive, surpassing industry averages. With a net margin of <strong>20.07%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> LeMaitre Vascular's ROE excels beyond industry benchmarks, reaching <strong>3.35%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> LeMaitre Vascular's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.41%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> LeMaitre Vascular's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.55</strong>.</p>
<p><a href="https://www.benzinga.com/quote/LMAT/earnings"><strong>To track all earnings releases for LeMaitre Vascular visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


LMAT

A Look at LeMaitre Vascular's Upcoming Earnings Report

<p><strong>Perdoceo Education</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Perdoceo Education will report an <strong>earnings per share</strong> (EPS) of $0.66. </p>
<p>Perdoceo Education bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.02, leading to a 5.9% drop in the share price the following trading session.</p>
<p>Here's a look at Perdoceo Education's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.48</td>
<td>0.53</td>
<td>0.58</td>
<td>0.53</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.50</td>
<td>0.59</td>
<td>0.60</td>
<td>0.60</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>12.0%</td>
<td>-1.0%</td>
<td>31.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039678_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Perdoceo Education were trading at $25.22 as of April 29. Over the last 52-week period, shares are up 4.37%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Insights Shared by Analysts on Perdoceo Education</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Perdoceo Education.</p>
<p>A total of 3 analyst ratings have been received for Perdoceo Education, with the consensus rating being Outperform. The average one-year price target stands at $34.0, suggesting a potential 34.81% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Afya, Universal Technical and KinderCare Learning, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Sell trajectory for Afya, with an average 1-year price target of $16.0, suggesting a potential 36.56% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Universal Technical, with an average 1-year price target of $34.2, suggesting a potential 35.61% upside.</li>
<li>Analysts currently favor an Buy trajectory for KinderCare Learning, with an average 1-year price target of $24.5, suggesting a potential 2.85% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Afya, Universal Technical and KinderCare Learning, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Perdoceo Education</td>
<td>Outperform</td>
<td>19.28%</td>
<td>$141.23M</td>
<td>3.32%</td>
</tr>
<tr>
<td>Afya</td>
<td>Sell</td>
<td>0.93%</td>
<td>$517.10M</td>
<td>3.58%</td>
</tr>
<tr>
<td>Universal Technical</td>
<td>Outperform</td>
<td>15.30%</td>
<td>$101.29M</td>
<td>8.20%</td>
</tr>
<tr>
<td>KinderCare Learning</td>
<td>Buy</td>
<td>4.69%</td>
<td>$133.26M</td>
<td>-24.29%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Perdoceo Education ranks first in revenue growth among its peers. It has the lowest gross profit and return on equity.</p>
<h3>About Perdoceo Education</h3>
<p>Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.</p>
<h3>A Deep Dive into Perdoceo Education's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Perdoceo Education's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>19.28%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Perdoceo Education's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>17.83%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>3.32%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.67%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.14</strong>, Perdoceo Education adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/PRDO/earnings"><strong>To track all earnings releases for Perdoceo Education visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


PRDO

An Overview of Perdoceo Education's Earnings

<p>Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) in the last three months.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $67.29, a high estimate of $89.00, and a low estimate of $55.00. A decline of 6.72% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039672_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The standing of Signet Jewelers among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Mauricio Serna</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$89.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$62.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$55.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Signet Jewelers. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Signet Jewelers compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Signet Jewelers's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Signet Jewelers's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SIG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Signet Jewelers analyst ratings.</strong></a></p>
<h2>Discovering Signet Jewelers: A Closer Look</h2>
<p>Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall &amp; Outlet.</p>
<h3>Signet Jewelers: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Signet Jewelers's financials over 3M reveals challenges. As of 31 January, 2025, the company experienced a decline of approximately <strong>-5.81%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Signet Jewelers's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>4.28%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Signet Jewelers's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>5.51%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Signet Jewelers's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.76%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Signet Jewelers's debt-to-equity ratio is below the industry average. With a ratio of <b>0.64</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Beyond The Numbers: 7 Analysts Discuss Signet Jewelers Stock

<p>Frontier Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-01. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Frontier Group Holdings will report an <strong>earnings per share</strong> (EPS) of $-0.04.</p>
<p>The announcement from Frontier Group Holdings is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>During the last quarter, the company reported an EPS beat by $0.10, leading to a 0.0% drop in the share price on the subsequent day.</p>
<p>Here's a look at Frontier Group Holdings's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.13</td>
<td>-0.03</td>
<td>0.15</td>
<td>-0.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.23</td>
<td>-0.05</td>
<td>0.14</td>
<td>-0.09</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>15.0%</td>
<td>0.0%</td>
<td>-2.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039667_0.png" alt="eps graph" /></p>
<h3>Frontier Group Holdings Share Price Analysis</h3>
<p>Shares of Frontier Group Holdings were trading at $3.13 as of April 29. Over the last 52-week period, shares are down 49.24%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analyst Observations about Frontier Group Holdings</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Frontier Group Holdings.</p>
<p>Analysts have provided Frontier Group Holdings with 11 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $7.02, suggesting a potential 124.28% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Allegiant Travel, Sun Country Airlines and Blade Air Mobility, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Allegiant Travel, with an average 1-year price target of $64.43, suggesting a potential 1958.47% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Sun Country Airlines, with an average 1-year price target of $14.5, suggesting a potential 363.26% upside.</li>
<li>Analysts currently favor an Buy trajectory for Blade Air Mobility, with an average 1-year price target of $6.5, suggesting a potential 107.67% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>Within the peer analysis summary, vital metrics for Allegiant Travel, Sun Country Airlines and Blade Air Mobility are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Frontier Group Holdings</td>
<td>Neutral</td>
<td>12.46%</td>
<td>$83M</td>
<td>9.19%</td>
</tr>
<tr>
<td>Allegiant Travel</td>
<td>Neutral</td>
<td>2.73%</td>
<td>$115.95M</td>
<td>-18.10%</td>
</tr>
<tr>
<td>Sun Country Airlines</td>
<td>Neutral</td>
<td>6.05%</td>
<td>$58.63M</td>
<td>2.39%</td>
</tr>
<tr>
<td>Blade Air Mobility</td>
<td>Buy</td>
<td>14.49%</td>
<td>$12.59M</td>
<td>-4.30%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Frontier Group Holdings ranks in the middle for revenue growth among its peers. It ranks at the bottom for gross profit. It ranks at the top for return on equity.</p>
<h3>Delving into Frontier Group Holdings's Background</h3>
<p>Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.</p>
<h3>Frontier Group Holdings: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Frontier Group Holdings's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>12.46%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Frontier Group Holdings's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>5.29%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Frontier Group Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>9.19%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Frontier Group Holdings's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>0.88%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Frontier Group Holdings's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>7.4</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<p><a href="https://www.benzinga.com/quote/ULCC/earnings"><strong>To track all earnings releases for Frontier Group Holdings visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ULCC

Insights into Frontier Group Holdings's Upcoming Earnings

<p>4 analysts have expressed a variety of opinions on Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Equity Residential and provided 12-month price targets. The average target is $78.25, accompanied by a high estimate of $80.00 and a low estimate of $76.00. Surpassing the previous average price target of $77.56, the current average has increased by 0.89%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039665_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Equity Residential among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$82.25</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$79.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$76.00</td>
<td>$74.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Equity Residential. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Equity Residential compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Equity Residential's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Equity Residential's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EQR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Equity Residential analyst ratings.</strong></a></p>
<h2>Delving into Equity Residential's Background</h2>
<p>Equity Residential owns a portfolio of 311 apartment communities with around 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.</p>
<h3>Equity Residential: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Equity Residential's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>5.4%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Real Estate sector.</p>
<p><strong>Net Margin:</strong> Equity Residential's net margin excels beyond industry benchmarks, reaching <strong>54.61%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Equity Residential's ROE excels beyond industry benchmarks, reaching <strong>3.83%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Equity Residential's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>2.01%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.76</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Assessing Equity Residential: Insights From 4 Financial Analysts

<p><strong>Cohu</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHU#NASDAQ">COHU</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Cohu will report an <strong>earnings per share</strong> (EPS) of $-0.17. </p>
<p>Anticipation surrounds Cohu's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.06, which was followed by a 1.63% drop in the share price the next day.</p>
<p>Here's a look at Cohu's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.09</td>
<td>-0.07</td>
<td>-0.02</td>
<td>-0.01</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.15</td>
<td>-0.08</td>
<td>-0.01</td>
<td>0.01</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>10.0%</td>
<td>-12.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039659_0.png" alt="eps graph" /></p>
<h3>Cohu Share Price Analysis</h3>
<p>Shares of Cohu were trading at $16.5 as of April 29. Over the last 52-week period, shares are down 47.92%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/COHU/earnings"><strong>To track all earnings releases for Cohu visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


COHU

Cohu's Earnings: A Preview

<p>In the latest quarter, 11 analysts provided ratings for Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Honeywell Intl, revealing an average target of $230.18, a high estimate of $260.00, and a low estimate of $178.00. Experiencing a 1.52% decline, the current average is now lower than the previous average price target of $233.73. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039653_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Honeywell Intl. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$225.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$226.00</td>
<td>$211.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$243.00</td>
<td>$247.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$229.00</td>
<td>$253.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$178.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$247.00</td>
<td>$251.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$217.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$251.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$236.00</td>
<td>$253.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$220.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Nicole Deblase</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$260.00</td>
<td>$236.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Honeywell Intl. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Honeywell Intl compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Honeywell Intl's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Honeywell Intl's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HON/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Honeywell Intl analyst ratings.</strong></a></p>
<h2>About Honeywell Intl</h2>
<p>Honeywell traces its roots to 1885 with Albert Butz's firm, Butz Thermo-Electric Regulator, which produced a predecessor to the modern thermostat. Other inventions by Honeywell include biodegradable detergent and autopilot. Today, Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. It operates through four business segments: aerospace technologies (37% of 2023 company revenue), industrial automation (29%), energy and sustainability solutions (17%), and building automation (17%). Recently, Honeywell has made several portfolio changes to focus on fewer end markets and align with a set of secular growth trends. The firm is working diligently to expand its installed base, deriving around 30% of its revenue from recurring aftermarket services.</p>
<h3>Unraveling the Financial Story of Honeywell Intl</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Honeywell Intl showcased positive performance, achieving a revenue growth rate of <strong>6.86%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Honeywell Intl's net margin is impressive, surpassing industry averages. With a net margin of <strong>12.74%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Honeywell Intl's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>7.13%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Honeywell Intl's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.73%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Honeywell Intl's debt-to-equity ratio is below the industry average at <strong>1.73</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Deep Dive Into Honeywell Intl Stock: Analyst Perspectives (11 Ratings)

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Morgan Stanley</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MS, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Morgan Stanley.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 30% bullish and 70%, bearish.</p>
<p>Out of all of the special options we uncovered, 6 are puts, for a total amount of $184,271, and 4 are calls, for a total amount of $125,960.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $120.0 for Morgan Stanley over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Morgan Stanley's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Morgan Stanley's whale trades within a strike price range from $50.0 to $120.0 in the last 30 days. </p>
<h3>Morgan Stanley 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746039650_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$7.3</td>
<td>$7.2</td>
<td>$7.27</td>
<td>$115.00</td>
<td>$34.1K</td>
<td>3.1K</td>
<td align="right">12</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$64.95</td>
<td>$64.3</td>
<td>$64.78</td>
<td>$50.00</td>
<td>$32.3K</td>
<td>57</td>
<td align="right">18</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$65.35</td>
<td>$64.45</td>
<td>$64.77</td>
<td>$50.00</td>
<td>$32.3K</td>
<td>57</td>
<td align="right">8</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$64.85</td>
<td>$64.15</td>
<td>$64.66</td>
<td>$50.00</td>
<td>$32.3K</td>
<td>57</td>
<td align="right">13</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.93</td>
<td>$1.92</td>
<td>$1.93</td>
<td>$100.00</td>
<td>$31.6K</td>
<td>12.6K</td>
<td align="right">168</td>
</tr>
</tbody>
</table>
</p>
<h3>About Morgan Stanley</h3>
<p>Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 24% of its total revenue is from outside the Americas. The company had over $6 trillion of client assets as well as around 70,000 employees at the end of 2024.</p>
<p>In light of the recent options history for Morgan Stanley, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Morgan Stanley</h3>
<ul>
<li>With a trading volume of 3,303,083, the price of MS is down by -1.12%, reaching $114.0.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 77 days from now.</li>
</ul>
<h3>Expert Opinions on Morgan Stanley</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $129.8.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Neutral rating for Morgan Stanley, targeting a price of $125.<br />
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Morgan Stanley, maintaining a target price of $120.<br />
&#x2A; An analyst from JP Morgan persists with their Neutral rating on Morgan Stanley, maintaining a target price of $122.<br />
&#x2A; An analyst from B of A Securities persists with their Buy rating on Morgan Stanley, maintaining a target price of $144.<br />
&#x2A; An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Morgan Stanley, which currently sits at a price target of $138. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Morgan Stanley with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Comments

Bird Global Inc Class A

Vendite allo scoperto

Bird Global Inc Class A (OTC:BRDSQ) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO